At Amgen, we are committed to the relentless pursuit of breakthroughs for cancer patients and their families. We have a deep and diverse pipeline of cutting-edge therapeutic approaches that aim to improve outcomes. Amgen has been pursuing novel treatment approaches for more than 40 years. We never stop looking toward the next frontier of innovation to bring the greatest potential benefit to patients. Amgen is dedicated to addressing unmet needs, pursuing breakthroughs, transforming cancer care together and driving health system sustainability. The Amgen Oncology portfolio is currently comprised of 14 innovative products for both liquid and solid tumors.
Click Here to Join
Topic: AMGEN Product Discussion
Time: Nov 10, 2021 05:00 PM Pacific Time (US and Canada)
Meeting ID: 780 5784 5920